Prevalence, Burden, and Disability Associated with Co-occurring Binge Eating Among U.S. Adults with Cannabis-Involved Drug Use Disorder
Abstract
Despite established appetite-stimulating effects of cannabis use, binge eating is seldom assessed in these samples. Its prevalence, clinical importance, and demographic reach among people with cannabis-involved drug use disorder are largely unknown. We analyzed 12,591 adults from the Collaborative Psychiatric Epidemiology Surveys who completed the eating disorder and substance use modules. Using design-weighted estimation, we estimated prevalence of binge eating among adults with a cannabis-involved drug use disorder and examined whether binge eating marks greater burden and disability and whether it differs by demographic group. Recurrent binge eating affected 11.2% of adults with a cannabis-involved drug use disorder (95% CI [8.4, 14.7]). Separately, 5.5% met criteria for DSM-IV binge eating disorder. Prevalence rose across levels of cannabis involvement (adjusted OR per level = 2.11, 95% CI [1.75, 2.55]). Adults with both conditions had the highest prevalence of suicidal ideation, suicide attempts, major depression, and generalized anxiety disorder. At least one lifetime suicide attempt was reported by 27.8% of this group and by only 3.3% of adults with neither condition. Binge eating alone was associated with a level of functional disability comparable to cannabis-involved drug use disorder alone, while adults with both conditions had the highest WHODAS time out of role and role impairment scores. Among adults with cannabis-involved drug use disorder, binge eating also marked a more damaging drug course. Among adults with a cannabis-involved drug use disorder, recurrent binge eating was more prevalent among women (17.4%) than men (8.6%). Men nevertheless made up an estimated 54.1% of affected adults. Prevalence ranged from 9.7% to 12.3% across racial and ethnic groups. Findings indicate that binge eating is common and linked with adverse outcomes among those with cannabis-involved drug use disorder, thus warranting targeted interventions.
Related
- Incidence of heavy menstrual bleeding and prevalence of co-occurring conditions from seven countries across Europe and North America: an EHDEN real-world data study
- The Epidemiology of Disability in Saudi Arabia: National Prevalence, Functional Multimorbidity, and Age-Stratified Self-Reported Causes
- Between borders and barriers: disability prevalence, pregnancy outcomes and maternal care access on the Thai-Myanmar border, a mixed methods study
- Cannabis Use and Binge Eating in Emerging Adults: High Prevalence and High Burden Across Ten Years of the Healthy Minds Study
- Cancer type-specific profiling of chromatin regulator mutations identifies recurrent and co-occurring gene sets associated with improved survival following immune checkpoint therapy
BibTeX
@misc{lampe2026prevalence,
title = {{Prevalence, Burden, and Disability Associated with Co-occurring Binge Eating Among U.S. Adults with Cannabis-Involved Drug Use Disorder}},
author = {Elizabeth W. Lampe and Ya-Wen Yama Chang and Nicholas C. Jacobson},
howpublished = {PsyArXiv},
year = {2026},
month = nov,
doi = {10.31234/osf.io/ut5g2_v1},
url = {https://osf.io/preprints/psyarxiv/ut5g2_v1/},
note = {CC BY 4.0},
}
RIS
TY - UNPB
TI - Prevalence, Burden, and Disability Associated with Co-occurring Binge Eating Among U.S. Adults with Cannabis-Involved Drug Use Disorder
AU - Elizabeth W. Lampe
AU - Ya-Wen Yama Chang
AU - Nicholas C. Jacobson
PY - 2026
DA - 2026/11/02
PB - PsyArXiv
DO - 10.31234/osf.io/ut5g2_v1
UR - https://osf.io/preprints/psyarxiv/ut5g2_v1/
AB - Despite established appetite-stimulating effects of cannabis use, binge eating is seldom assessed in these samples. Its prevalence, clinical importance, and demographic reach among people with cannabis-involved drug use disorder are largely unknown. We analyzed 12,591 adults from the Collaborative Psychiatric Epidemiology Surveys who completed the eating disorder and substance use modules. Using design-weighted estimation, we estimated prevalence of binge eating among adults with a cannabis-involved drug use disorder and examined whether binge eating marks greater burden and disability and whether it differs by demographic group. Recurrent binge eating affected 11.2% of adults with a cannabis-involved drug use disorder (95% CI [8.4, 14.7]). Separately, 5.5% met criteria for DSM-IV binge eating disorder. Prevalence rose across levels of cannabis involvement (adjusted OR per level = 2.11, 95% CI [1.75, 2.55]). Adults with both conditions had the highest prevalence of suicidal ideation, suicide attempts, major depression, and generalized anxiety disorder. At least one lifetime suicide attempt was reported by 27.8% of this group and by only 3.3% of adults with neither condition. Binge eating alone was associated with a level of functional disability comparable to cannabis-involved drug use disorder alone, while adults with both conditions had the highest WHODAS time out of role and role impairment scores. Among adults with cannabis-involved drug use disorder, binge eating also marked a more damaging drug course. Among adults with a cannabis-involved drug use disorder, recurrent binge eating was more prevalent among women (17.4%) than men (8.6%). Men nevertheless made up an estimated 54.1% of affected adults. Prevalence ranged from 9.7% to 12.3% across racial and ethnic groups. Findings indicate that binge eating is common and linked with adverse outcomes among those with cannabis-involved drug use disorder, thus warranting targeted interventions.
ER -